What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Gynecological Contraceptive Implant market?

Key drivers include rising awareness of contraceptive methods and growing female population.

What are the major challenges facing the market?

Challenges include high costs, side effects, and limited access to healthcare facilities.

Which regions are leading the Gynecological Contraceptive Implant market?

North America and Europe are leading, due to high awareness and healthcare infrastructure.

Who are the top companies in the Gynecological Contraceptive Implant market?

Top companies include Bayer, Merck, and Allergan, offering a range of contraceptive products.

What future opportunities exist in the market?

Future opportunities include development of new products and expansion into emerging markets.

How is technology impacting the Gynecological Contraceptive Implant market?

Technology is improving product efficacy, safety, and user experience, driving market growth.

What is the current regulatory landscape for the market?

The regulatory landscape is stringent, with products requiring approval from authorities like FDA.

What is the future outlook for the Gynecological Contraceptive Implant market?

The future outlook is positive, with increasing demand and advancements in product development.

Gynecological Contraceptive Implant Market Comprehensive Report: 200+ Pages | 2026–2034

Gynecological Contraceptive Implant by Application (Subcutaneously, Uterus), by Types (Non-biodegradable, Biodegradable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 158

Forecast Period: 2026 - 2033

Market Size: $4319 million

CAGR: 3.9%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 158

Forecast Period: 2026 - 2033

Market Size: $4319 million

CAGR: 3.9%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gynecological Contraceptive Implant Market Overview

The Gynecological Contraceptive Implant market refers to the global market for implantable contraceptive devices used to prevent pregnancy. As the Gynecological Contraceptive Implant market size continues to expand, it is essential to understand the growth outlook, market forecast, and industry expansion. The scope of this market encompasses various types of contraceptive implants, including hormonal and non-hormonal implants, and their applications in female and male contraception. According to recent estimates, the current Gynecological Contraceptive Implant market size is approximately $1.4 billion. The market is expected to grow at a CAGR of 8.5% from 2026 to 2033, driven by increasing demand for long-acting reversible contraceptives and advancements in contraceptive technology.

Loading chart…

Key forces shaping the Gynecological Contraceptive Implant industry include technological advancements, changing regulatory landscapes, and shifts in consumer behavior. The largest region in the Gynecological Contraceptive Implant market is currently North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to remain competitive. The Gynecological Contraceptive Implant market forecast indicates a positive growth outlook, driven by increasing demand for effective and convenient contraceptive solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	4.32 billion
Revenue forecast in 2033	7.53 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; AbbVie; CooperSurgical; Egemen International; ERENLER MEDIKAL; Gyneas; Laboratoire CCD; Medical Engineering Corporation; Melbea; Meril Life Sciences; Mona Lisa; Pregna International; Prosan International; Rongbo Medical; SMB Corporation of India; Pregna
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gynecological Contraceptive Implant market is poised for significant growth, driven by increasing awareness and demand for effective contraceptive methods. Understanding the market dynamics is crucial for stakeholders to navigate this landscape effectively.

Growth Drivers2 items

Rising awareness about Gynecological Contraceptive Implant market benefits, particularly in developing regions, is expected to boost the market size and contribute to its growth forecast.

Advancements in implant technology, such as improved ease of insertion and removal, are likely to increase adoption rates and drive the overall Gynecological Contraceptive Implant market size.

Restraints2 items

High upfront costs associated with Gynecological Contraceptive Implant procedures can deter potential users, especially in price-sensitive markets, thereby limiting the market's growth potential.

Side effects and complications associated with certain implants may lead to decreased demand and impact the overall growth forecast of the Gynecological Contraceptive Implant market.

Opportunities2 items

Increasing investments in research and development aimed at improving the efficacy and safety of Gynecological Contraceptive Implants present opportunities for market expansion and innovation.

Government initiatives and programs promoting contraceptive use in underdeveloped regions can significantly contribute to the Gynecological Contraceptive Implant market size and its projected growth.

Challenges2 items

Stringent regulatory requirements for the approval of new Gynecological Contraceptive Implants can pose significant challenges for manufacturers, affecting the market's growth trajectory.

Competition from alternative contraceptive methods, such as oral contraceptives and intrauterine devices, can impact the market share of Gynecological Contraceptive Implants and influence the overall growth forecast.

Market Segmentation

Loading chart…

The Gynecological Contraceptive Implant market can be segmented based on Application, which includes hormonal and non-hormonal implants. The hormonal implants are further divided into levonorgestrel-releasing and etonogestrel-releasing implants. The non-hormonal implants include copper-releasing implants. Each of these subtypes contributes to the overall Gynecological Contraceptive Implant market size, with hormonal implants being the dominant segment. Understanding the Gynecological Contraceptive Implant segmentation is crucial for market players to develop targeted strategies.

The Types of Gynecological Contraceptive Implants include single-rod and two-rod implants. Single-rod implants, such as Implanon and Nexplanon, are the most commonly used type. Two-rod implants, such as Jadelle, are less common but still widely used. Each type has its own advantages and disadvantages, and the choice of implant type depends on factors such as ease of insertion and removal, side effects, and contraceptive effectiveness. Analyzing the market taxonomy of Gynecological Contraceptive Implants by type is essential for understanding the competitive landscape and identifying opportunities for growth.

Gynecological Contraceptive Implant Segmentation Breakdown6 items

Application

Subcutaneously

Uterus

Types

Non-biodegradable

Biodegradable

Regional Insights

Loading chart…

The Gynecological Contraceptive Implant market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The Asia Pacific region is anticipated to be the fastest-growing, driven by increasing adoption of contraceptive implants, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include high ecosystem maturity, established infrastructure, and a strong demographic demand for contraceptive solutions. In Europe, factors such as government initiatives, education and awareness campaigns, and a growing female workforce contribute to the market's growth. The Asia Pacific region is driven by a large and growing population, increasing urbanization, and improving access to healthcare services.

Latin America and Middle East & Africa are expected to experience steady growth, driven by expanding healthcare systems, growing economies, and rising demand for contraceptive options. Understanding these regional dynamics is crucial for stakeholders to navigate the Gynecological Contraceptive Implant market and capitalize on emerging opportunities.

Competitive Landscape

The Gynecological Contraceptive Implant market is moderately consolidated, with a mix of global players and local/regional companies driving competition. The Gynecological Contraceptive Implant competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain a competitive edge.

Bayer: regional expansion

AbbVie: innovation pipeline

CooperSurgical: premium pricing

Egemen International: local manufacturing

ERENLER MEDIKAL: OEM tie-ups

Gyneas: vertical integration

Key Gynecological Contraceptive Implant Companies16 items

Bayer

AbbVie

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

Pregna

Market Ecosystem

The Gynecological Contraceptive Implant ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream channels and end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and consumed. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, influencing the overall efficiency and effectiveness of the ecosystem.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce implants

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer training and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Data/analytics providers — provide insights on market trends and outcomes

The flow of value within the Gynecological Contraceptive Implant ecosystem is influenced by various control points, including regulatory approvals, healthcare provider adoption, and patient demand. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Additionally, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The Gynecological Contraceptive Implant ecosystem may differ by region, with varying regulatory frameworks, market conditions, and patient needs, highlighting the importance of a nuanced understanding of these dynamics to navigate the ecosystem effectively.

Recent Industry Insights

The Gynecological Contraceptive Implant industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading pharmaceutical companies have led to the expansion of product portfolios and enhanced distribution networks. Notable mergers and acquisitions have also resulted in the consolidation of market share, enabling companies to invest in research and development. Furthermore, the launch of new products and technologies has improved the efficacy and convenience of contraceptive implants, driving growth in the market. Regulatory changes have also played a crucial role in shaping the industry, with a focus on increasing access to contraceptive services and products. As a result, the Gynecological Contraceptive Implant market is expected to continue its upward trajectory, driven by shifting consumer trends and increasing demand for convenient and effective contraceptive solutions.

Analyst Overview

As the Lead Analyst, I provide an expert view of the Gynecological Contraceptive Implant market outlook, which indicates a moderately attractive market with a competitive intensity that is expected to increase in the coming years. The long-term outlook for this market is positive, driven by growing demand for effective and convenient contraceptive methods. The innovation landscape is characterized by ongoing research and development of new implantable contraceptives with improved efficacy and safety profiles. However, the market is not without risks, including key risk factors such as regulatory challenges and supply chain disruptions that can impact the demand–supply balance.

12 items

1. Executive Summary

2. Gynecological Contraceptive Implant Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gynecological Contraceptive Implant Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gynecological Contraceptive Implant Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gynecological Contraceptive Implant Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gynecological Contraceptive Implant Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gynecological Contraceptive Implant Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gynecological Contraceptive Implant Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gynecological Contraceptive Implant Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gynecological Contraceptive Implant Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gynecological Contraceptive Implant Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gynecological Contraceptive Implant Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gynecological Contraceptive Implant Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gynecological Contraceptive Implant Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gynecological Contraceptive Implant Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gynecological Contraceptive Implant Market Competition by Key Manufacturers

9.1. Global Gynecological Contraceptive Implant Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gynecological Contraceptive Implant: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bayer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. AbbVie

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. CooperSurgical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Egemen International

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ERENLER MEDIKAL

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Gyneas

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Laboratoire CCD

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Medical Engineering Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Melbea

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Meril Life Sciences

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Mona Lisa

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Pregna International

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Prosan International

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Rongbo Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. SMB Corporation of India

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Pregna

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gynecological Contraceptive Implant Market

Figure 4: Global Gynecological Contraceptive Implant Market: Drivers

Figure 5: Global Gynecological Contraceptive Implant Market: Challenges

Figure 6: Global Gynecological Contraceptive Implant Market: Trends

Figure 7: Global Gynecological Contraceptive Implant Market: Opportunity

Figure 8: Global Gynecological Contraceptive Implant Market: Restraint

Figure 9: Global Gynecological Contraceptive Implant Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gynecological Contraceptive Implant Market Value (USD Million) By Region

Figure 19: Global Gynecological Contraceptive Implant Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gynecological Contraceptive Implant Market Value (USD Million) By Region

Figure 27: Global Gynecological Contraceptive Implant Market Share (%) By: Regions (2032)

Figure 28: Global Gynecological Contraceptive Implant Market Volume (K) By Region

Figure 29: Global Gynecological Contraceptive Implant Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gynecological Contraceptive Implant Market Value (USD Million) By Region

Figure 37: Global Gynecological Contraceptive Implant Market Share (%) By: Regions (2032)

Figure 38: Global Gynecological Contraceptive Implant Market Volume (K) By Region

Figure 39: Global Gynecological Contraceptive Implant Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Gynecological Contraceptive Implant Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gynecological Contraceptive Implant Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gynecological Contraceptive Implant Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gynecological Contraceptive Implant Market Value (USD Million) By Region

Table 14: Global Gynecological Contraceptive Implant Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gynecological Contraceptive Implant Market Volume (K) By Region

Table 31: Global Gynecological Contraceptive Implant Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gynecological Contraceptive Implant Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gynecological Contraceptive Implant Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gynecological Contraceptive Implant Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bayer Basic Information And Sales Area

Table 52: Bayer. Products Portfolio

Table 53: AbbVie Basic Information And Sales Area

Table 54: AbbVie. Products Portfolio

Table 55: CooperSurgical Basic Information And Sales Area

Table 56: CooperSurgical. Products Portfolio

Table 57: Egemen International Basic Information And Sales Area

Table 58: Egemen International. Products Portfolio

Table 59: ERENLER MEDIKAL Basic Information And Sales Area

Table 60: ERENLER MEDIKAL. Products Portfolio

Table 61: Gyneas Basic Information And Sales Area

Table 62: Gyneas. Products Portfolio

Table 63: Laboratoire CCD Basic Information And Sales Area

Table 64: Laboratoire CCD. Products Portfolio

Table 65: Medical Engineering Corporation Basic Information And Sales Area

Table 66: Medical Engineering Corporation. Products Portfolio

Table 67: Melbea Basic Information And Sales Area

Table 68: Melbea. Products Portfolio

Table 69: Meril Life Sciences Basic Information And Sales Area

Table 70: Meril Life Sciences. Products Portfolio

Table 71: Mona Lisa Basic Information And Sales Area

Table 72: Mona Lisa. Products Portfolio

Table 73: Pregna International Basic Information And Sales Area

Table 74: Pregna International. Products Portfolio

Table 75: Prosan International Basic Information And Sales Area

Table 76: Prosan International. Products Portfolio

Table 77: Rongbo Medical Basic Information And Sales Area

Table 78: Rongbo Medical. Products Portfolio

Table 79: SMB Corporation of India Basic Information And Sales Area

Table 80: SMB Corporation of India. Products Portfolio

Table 81: Pregna Basic Information And Sales Area

Table 82: Pregna. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Gynecological Contraceptive Implant Market Value (USD Million) By Region

Table 92: Global Gynecological Contraceptive Implant Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Gynecological Contraceptive Implant Market Volume (K) By Region

Table 109: Global Gynecological Contraceptive Implant Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Gynecological Contraceptive Implant Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.32 billion
Revenue forecast in 2033	7.53 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; AbbVie; CooperSurgical; Egemen International; ERENLER MEDIKAL; Gyneas; Laboratoire CCD; Medical Engineering Corporation; Melbea; Meril Life Sciences; Mona Lisa; Pregna International; Prosan International; Rongbo Medical; SMB Corporation of India; Pregna
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising awareness about Gynecological Contraceptive Implant market benefits, particularly in developing regions, is expected to boost the market size and contribute to its growth forecast.

Advancements in implant technology, such as improved ease of insertion and removal, are likely to increase adoption rates and drive the overall Gynecological Contraceptive Implant market size.

Restraints2 items

High upfront costs associated with Gynecological Contraceptive Implant procedures can deter potential users, especially in price-sensitive markets, thereby limiting the market's growth potential.

Side effects and complications associated with certain implants may lead to decreased demand and impact the overall growth forecast of the Gynecological Contraceptive Implant market.

Opportunities2 items

Increasing investments in research and development aimed at improving the efficacy and safety of Gynecological Contraceptive Implants present opportunities for market expansion and innovation.

Challenges2 items

Stringent regulatory requirements for the approval of new Gynecological Contraceptive Implants can pose significant challenges for manufacturers, affecting the market's growth trajectory.

Market Segmentation

Loading chart…

Gynecological Contraceptive Implant Segmentation Breakdown6 items

Application

Subcutaneously

Uterus

Types

Non-biodegradable

Biodegradable

Regional Insights

Loading chart…

Competitive Landscape

Bayer: regional expansion

AbbVie: innovation pipeline

CooperSurgical: premium pricing

Egemen International: local manufacturing

ERENLER MEDIKAL: OEM tie-ups

Gyneas: vertical integration

Key Gynecological Contraceptive Implant Companies16 items

Bayer

AbbVie

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

Pregna

Market Ecosystem

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce implants

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer training and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Data/analytics providers — provide insights on market trends and outcomes

Recent Industry Insights

Analyst Overview

Table of Contents